🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
We propose to conduct a phase 2 study to assess whether the addition of aci...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2013-12
Trial ID
NCT02050321
Treatments Being Tested
This multi-center study evaluates the safety and efficacy of vemurafenib in...
Status
Completed
Location
University "Mother Theresa" Hospital Center; Oncology Department
Start Date
2011-03-01
Trial ID
NCT01307397
Treatments Being Tested
This randomized, open-label study evaluated the efficacy, safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01006980
Treatments Being Tested
Approximately 40-60 % of cutaneous melanomas select for a mutation in a pro...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-09
Trial ID
NCT01942993
Treatments Being Tested
This is a Phase III, double-blinded, placebo-controlled, randomized, multic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-01-13
Trial ID
NCT02908672
Treatments Being Tested
This study will evaluate the efficacy and safety of cobimetinib plus atezol...
Status
Completed
Location
Instituto Nacional de Cancer - INCa; Oncologia
Start Date
2018-12-13
Trial ID
NCT03625141
Treatments Being Tested
A Phase II, open label, non-randomized, multiple-arm, single-center clinica...
Status
Recruiting
Location
Cancer hospital Chinese Academy of Medical Sciences
Start Date
2020-08-15
Trial ID
NCT04423185
This is a single arm, multicenter, open label, and non-randomized clinical ...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-05-23
Trial ID
NCT02768207
Treatments Being Tested